ABVIX
Price
$17.75
Change
+$0.10 (+0.57%)
Updated
Jul 3 closing price
Net Assets
439.06M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

ABVIX vs VIVAX

Header iconABVIX vs VIVAX Comparison
Open Charts ABVIX vs VIVAXBanner chart's image
AB Large Cap Value I
Price$17.75
Change+$0.10 (+0.57%)
VolumeN/A
Net Assets439.06M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
ABVIX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ABVIX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVIX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. ABVIX (439M). VIVAX pays higher dividends than ABVIX: VIVAX (2.06) vs ABVIX (1.21). ABVIX was incepted earlier than VIVAX: ABVIX (20 years) vs VIVAX (33 years). ABVIX (0.72) is less costly to investors than VIVAX (0.17). ABVIX is a more actively managed with annual turnover of: 53.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than ABVIX: VIVAX (3000) vs ABVIX (2000000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. ABVIX (1.71). VIVAX return over 5 years is better than : 80.14 vs. ABVIX (50.93).
ABVIXVIVAXABVIX / VIVAX
Total Expense Ratio0.650.17382%
Annual Report Gross Expense Ratio0.720.17424%
Fund Existence20 years33 years-
Gain YTD6.1606.20999%
Front LoadN/AN/A-
Min. Initial Investment2000000300066,667%
Min. Initial Investment IRAN/AN/A-
Net Assets439M189B0%
Annual Yield % from dividends1.212.0658%
Returns for 1 year1.7112.0414%
Returns for 3 years18.6735.1653%
Returns for 5 years50.9380.1464%
Returns for 10 years37.71115.7433%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings